← SynDRA
MIBAMPATOR
SynDRA canonical compound SYN0024866 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GRIA1 |
| Mechanism of action | Glutamate receptor modulator |
All known targets
Mechanisms of action (all sources)
- Glutamate receptor modulator
Cross-references
Synonyms
- LY-451395
- LY451395
- LY-450108
- AMPA agonists (Alzheimer's Disease), Lilly
- AMPA receptor agonist (agitation in Alzheimer's Disease), Eli Lilly
- A9V5BW73UU
- (R)-N-(2-(4'-(2-(Methylsulfonamido)ethyl)-[1,1'-biphenyl]-4-yl)propyl)propane-2-sulfonamide
- CHEMBL1277001
- N-((2R)-2-(4'-(2-((Methylsulfonyl)amino)ethyl)biphenyl-4-yl)propyl)propane-2-sulfonamide
- 2-Propanesulfonamide, N-((2R)-2-(4'-(2-((methylsulfonyl)amino)ethyl)(1,1'-biphenyl)-4-yl)propyl)-
- UNII-A9V5BW73UU
- N-[(2R)-2-[4-[4-[2-(methylsulfonylamino)ethyl]phenyl]phenyl]propyl]propane-2-sulfonamide
- Mibampator [USAN:INN]
- N-[(2R)-2-[4-[4-[2-(methanesulfonamido)ethyl]phenyl]phenyl]propyl]propane-2-sulfonamide
- MIBAMPATOR [INN]
- Mibampator (USAN/INN)
- MIBAMPATOR [USAN]
- MIBAMPATOR [WHO-DD]
- SCHEMBL3045499
- DTXSID20190977
- ZINC593414
- BCP28335
- BDBM50330415
- MFCD18251566
- CS-3166
- DB12717
- NCGC00390642-01
- HY-10934
- LY-451395; LY451395; Mibampator
- J3.560.858C
- D09931
- Q27273819
- (R)-N-(2-(4''-(2-(methylsulfonamido)ethyl)biphenyl-4-yl)propyl)propane-2-sulfonamide
- ((2R)-2-(4-(4-(2-((METHYLSULFONYL)AMINO)ETHYL)PHENYL)PHENYL)PROPYL)((1-METHYLETHYL)SULFONYL)AMINE
- 8SO
- mibampatorum
- RefChem:925842
Look up MIBAMPATOR in the interactive SynDRA portal →